Phamaceutical Composition Comprising an Extract of Artemisia scoparia for Preventing or Treating Metabolic Bone Disease-induced Bone Loss

摘要

The present invention relates to a pharmaceutical composition for the prevention or treatment of bone loss caused by bone metabolic disease, comprising the extract of Mugwort as an active ingredient. Mugwort extract exhibits the efficacy of preventing or treating bone loss caused by bone metabolic diseases by inhibiting the differentiation of osteoclasts and the activity of NFATc1. Due to the above efficacy, when the extract of the present invention is used, a pharmaceutical composition for preventing or treating bone loss caused by bone metabolic diseases that can be safely used in the human body without toxicity and side effects, or for preventing or improving bone loss caused by bone metabolic diseases A food composition can be provided.